Agf Investments Inc. Catalent, Inc. Transaction History

Agf Investments Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$94.19 - $124.49 $4,897 - $6,473	-52 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$109.17 - $142.35 $75.2 Million - $98.1 Million	-688,912 Reduced 99.99%	52 $7,000
Q2 2021 Aug 10, 2021	SELL	$100.34 - $115.69 $567,723 - $654,574	-5,658 Reduced 0.81%	688,964 $74.5 Million
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $3.25 Million - $4 Million	-31,969 Reduced 4.4%	694,622 $73.2 Million
Q4 2020 Feb 08, 2021	BUY	$85.88 - $105.36 $62.4 Million - $76.6 Million	726,591 New	726,591 $75.6 Million
Q2 2020 Aug 11, 2020	SELL	$48.02 - $79.04 $2,352 - $3,872	-49 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$36.95 - $62.95 $1,810 - $3,084	49 New	49 $3,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.